文化大學機構典藏 CCUR:Item 987654321/32107
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 46833/50693 (92%)
造访人次 : 11846558      在线人数 : 658
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于CCUR管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/32107


    题名: Common and unique mechanisms of Chinese herbal remedies on ischemic stroke mice revealed by transcriptome analyses
    作者: Shen, Yuh-Chiang
    Lu, Chung-Kuang
    Liou, Kuo-Tong
    Hou, Yu-Chang
    Lin, Yun-Lan
    Wang, Yea-Hwey
    Sun, Hsing-Jen
    Liao, Ko-Hsun
    Wang, Hsei-Wei
    贡献者: 國術系
    关键词: MEMORY ACQUISITION
    KAPPA-B
    DECOCTION
    TARGET
    REPERFUSION
    ACTIVATION
    MEDICINE
    GTPASES
    EVENTS
    INJURY
    日期: 2015-09-15
    上传时间: 2016-03-04 09:45:39 (UTC+8)
    摘要: Ethnopharmacological relevance: Four traditional Chinese herbal remedies (CHR) including Buyang Huanwu decoction (BHD), Xuefu Zhuyu decoction (XZD), Tianma Gouteng decoction (TGD) and Shengyu decoction (SYD) are popular used in treating brain-related dysfunction clinically with different syndrome/pattern based on traditional Chinese medicine (TCM) principles, yet their neuroprotective mechanisms are still unclear. Materials and methods: Mice were subjected to an acute ischemic stroke to examine the efficacy and molecular mechanisms of action underlying these CHR. Results: CHR treatment significantly enhanced the survival rate of stroke mice, with BHD being the most effective CHR. All CHR were superior to recombinant tissue-type plasminogen activator (rt-PA) treatment in successfully ameliorating brain function, infarction, and neurological deficits in stroke mice that also paralleled to improvements in blood-brain barrier damage, inflammation, apoptosis, and neurogenesis. Transcriptome analyses reveals that a total of 774 ischemia-induced probe sets were significantly modulated by four CHR, including 52 commonly upregulated genes and 54 commonly downregulated ones. Among them, activation of neurogenesis-associated signaling pathways and down-regulating inflammation and apoptosis pathways are key common mechanisms in ischemic stroke protection by all CHR. Besides, levels of plasma CX3CL1 and S100a9 in patients could be used as biomarkers for therapeutic evaluation before functional recovery could be observed. Conclusion: Our results suggest that using CHR, a combinatory cocktail therapy, is a better way than rt-PA for treating cerebral ischemic-associated diseases through modulating a common as well as a specific group of genes/pathways that may partially explain the syndrome differentiation and treatment principle in TCM. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
    關聯: JOURNAL OF ETHNOPHARMACOLOGY 卷: 173 頁碼: 370-382
    显示于类别:[技擊運動暨國術學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML464检视/开启


    在CCUR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈